Jochen Knaus

Jochen Knaus

Auto-generated profile, based on publicly available information

Jochen Knaus

Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Freiburg, Germany

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
SZStefanie Zimmermann
Stefanie Zimmermann
Peggy SekulaPeggy Sekula
Peggy Sekula
MVMoritz Venhoff
Moritz Venhoff
EMEdith Motschall
Edith Motschall
JKJochen Knaus
Jochen Knaus
MMMaja Mockenhaupt
Maja Mockenhaupt
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are rare, severe cutaneous adverse reactions that are associated with high mortality.1 SJS/TEN can be characterized by the detachment of necrotic epidermis and erosions of mucous membranes with different degrees of severity.2 The programmed cell death of the epidermis is believed to be induced by cytotoxic T cells and mediated by various cytokines.3,4 However, mainly because of their rareness, there is still a lack of an evidence-based standard treatment protocol for SJS/TEN.5 This review is a step toward such a protocol and reveals hypotheses on the most promising therapies essential for future studies.

1 January 2009 in The R Journal
Verified
Journal Article
Closed access
JKJochen Knaus
Jochen Knaus
CPChristine Porzelius
Christine Porzelius
HBHarald Binder
Harald Binder
GSGuido Schwarzer
Guido Schwarzer

17 July 2010 in Computational Statistics
Verified
Journal Article
Closed access
PDF file
MEManuel J. A. Eugster
Manuel J. A. Eugster
JKJochen Knaus
Jochen Knaus
CPChristine Porzelius
Christine Porzelius
MSMarkus Schmidberger
Markus Schmidberger
EVEsmeralda Vicedo
Esmeralda Vicedo

1 November 2021 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Open access
PSPascal Schlosser
Pascal Schlosser
JKJochen Knaus
Jochen Knaus
MSMaximilian Schmutz
Maximilian Schmutz
KDKonstanze Dohner
Konstanze Dohner
CPChristoph Plass
Christoph Plass
MSMartin Schumacher
Martin Schumacher
State-of-the art selection methods fail to identify weak but cumulative effects of features found in many high-dimensional omics datasets. Nevertheless, these features play an important role in certain diseases. We present Netboost, a three-step dimension reduction technique. First, a boosting-based filter is combined with the topological overlap measure to identify the essential edges of the network. Second, sparse hierarchical clustering is applied on the selected edges to identify modules and finally module information is aggregated by the first principal components. We demonstrate the application of the newly developed Netboost in combination with CoxBoost for survival prediction of DNA methylation and gene expression data from 180 acute myeloid leukemia (AML) patients and show, based on cross-validated prediction error curve estimates, its prediction superiority over variable selection on the full dataset as well as over an alternative clustering approach. The identified signature related to chromatin modifying enzymes was replicated in an independent dataset, the phase II AMLSG 12-09 study. In a second application we combine Netboost with Random Forest classification and improve the disease classification error in RNA-sequencing data of Huntington's disease mice. Netboost is a freely available Bioconductor R package for dimension reduction and hypothesis generation in high-dimensional omics applications.

17 October 2023 in Clinical Research in Cardiology
Verified
Journal Article
Open access
PDF file
SSSabine Steffens
Sabine Steffens
Katrin SchröderKatrin Schröder
Katrin Schröder
MKMartina Krüger
Martina Krüger
CMCristoph Maack
Cristoph Maack
KSKatrin Streckfuß-Bömeke
Katrin Streckfuß-Bömeke
PKPeter Kohl
Peter Kohl
The sharing and documentation of cardiovascular research data are essential for efficient use and reuse of data, thereby aiding scientific transparency, accelerating the progress of cardiovascular research and healthcare, and contributing to the reproducibility of research results. However, challenges remain. This position paper, written on behalf of and approved by the German Cardiac Society and German Centre for Cardiovascular Research, summarizes our current understanding of the challenges in cardiovascular research data management (RDM). These challenges include lack of time, awareness, incentives, and funding for implementing effective RDM; lack of standardization in RDM processes; a need to better identify meaningful and actionable data among the increasing volume and complexity of data being acquired; and a lack of understanding of the legal aspects of data sharing. While several tools exist to increase the degree to which data are findable, accessible, interoperable, and reusable (FAIR), more work is needed to lower the threshold for effective RDM not just in cardiovascular research but in all biomedical research, with data sharing and reuse being factored in at every stage of the scientific process. A culture of open science with FAIR research data should be fostered through education and training of early-career and established research professionals. Ultimately, FAIR RDM requires permanent, long-term effort at all levels. If outcomes can be shown to be superior and to promote better (and better value) science, modern RDM will make a positive difference to cardiovascular science and practice. The full position paper is available in the supplementary materials.

1 January 2013 in Methods of Information in Medicine
Verified
Journal Article
Closed access
PDF file
SHS. Hieke
S. Hieke
HBH. Binder
H. Binder
GSGuido Schwarzer
Guido Schwarzer
JKJ. Knaus
J. Knaus
Summary: Background: “Cloud” computing providers, such as the Amazon Web Services (AWS), offer stable and scalable computational resources based on hardware virtualization, with short, usually hourly, billing periods. The idea of pay-as-you-use seems appealing for biometry research units which have only limited access to university or corporate data center resources or grids.Objectives: This case study compares the costs of an existing heterogeneous on-site hardware pool in a Medical Biometry and Statistics department to a comparable AWS offer.Methods: The “total cost of ownership”, including all direct costs, is determined for the on-site hardware, and hourly prices are derived, based on actual system utilization during the year 2011. Indirect costs, which are difficult to quantify are not included in this comparison, but nevertheless some rough guidance from our experience is given. To indicate the scale of costs for a methodological research project, a simulation study of a permutation-based statistical approach is performed using AWS and on-site hardware.Results: In the presented case, with a system utilization of 25 –30 percent and 3 – 5-year amortization, on-site hardware can result in smaller costs, compared to hourly rental in the cloud dependent on the instance chosen. Renting cloud instances with sufficient main memory is a deciding factor in this comparison.Conclusions: Costs for on-site hardware may vary, depending on the specific infrastructure at a research unit, but have only moderate impact on the overall comparison and subsequent decision for obtaining affordable scientific computing resources. Overall utilization has a much stronger impact as it determines the actual computing hours needed per year. Taking this into account, cloud computing might still be a viable option for projects with limited maturity, or as a supplement for short peaks in demand.